GT: The Podcast Podcast By Glaucoma Today cover art

GT: The Podcast

GT: The Podcast

By: Glaucoma Today
Listen for free

About this listen

Keeping pace with the rapidly evolving glaucoma space, GT: The Podcast brings the latest thought-provoking information and insights on glaucoma to the ophthalmic community. Leading experts discuss the many developments advancing the understanding and treatment of the disease, with the collective goal of ushering in a new era of glaucoma care. GT: The Podcast is produced by Bryn Mawr Communications and Glaucoma Today.2024 Glaucoma Today Biological Sciences Science
Episodes
  • Survey Says: Choosing Treatment for a High-Risk Patient
    Jun 26 2025
    On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Erin Sieck, MD, and Arkadiy Yadgarov, MD, to review a real case from his practice involving a patient with elevated IOP on medication and a family history of glaucoma. The guests share their initial thoughts and concerns about the patient, discuss their treatment goals, and weigh their options for next steps. Later, they compare their opinions with the results of a social media poll of GT’s audience and find out what Dr. Singh did.
    Show more Show less
    35 mins
  • Career Change: Making the Vision Come to Life • Private Practice Versus Academia
    May 23 2025
    In this episode, two Glaucoma Today contributors dive into the topic of career paths in ophthalmology, comparing different options and offering pearls from their own experiences. Zahra Ali, MD, recaps her article, “Career Change: Making the Vision Come to Life,” which chronicles her personal transition from general ophthalmologist to glaucoma specialist. Then, Devang L. Bhoiwala, MD, recaps his article, “Private Practice Versus Academia,” which outlines the pros and cons of these two distinct career paths.
    Show more Show less
    15 mins
  • Metabolic Dysfunction in Glaucoma
    Apr 28 2025
    Flora Hui, PhD, and Pete A. Williams, PhD, recap their article, “Metabolic Dysfunction in Glaucoma: From Bench to Bedside (and Back Again),” which was featured in the January/February issue of Glaucoma Today. IOP lowering treatments are a mainstay of glaucoma management, but, while effective treatments exist, they do not target the neurodegenerative components of the disease. This article discusses the role of metabolic dysfunction in glaucoma and reviews nicotinamide treatment for neuroprotection.
    Show more Show less
    29 mins
No reviews yet